Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by M.J. Pencina, R.B. D' Agostino Sr, R.B. D' Agostino Jr, R.S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929)

Statistics in Medicine

Volumn 27, Issue 2, 2008, Pages 188-190

  Greenland, Philip ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DISEASE CLASSIFICATION; HEALTH STATISTICS; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; NOTE; PREDICTION; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

AREA UNDER CURVE; CARDIOVASCULAR DISEASES; HUMANS; MODELS, STATISTICAL; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; UNITED STATES;

EID: 38849130625     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2976     Document Type: Note

References (7)

1. Greenland P, Grundy S, Pasternak RC, Lenfant C. Problems on the pathway from risk assessment to risk reduction. Circulation 1998; 97(18):1761-1762.
2. Pencina MJ, D'Agostino Sr RB, D'Agostino Jr RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in Medicine, in this issue.
3. Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: the Framingham study. American Journal of Cardiology 1976; 38(1):46-51.
4. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. Journal of American Medical Association 2003; 290(7):891-897.
5. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. The New England Journal of Medicine 2004; 350(14):1387-1397.
6. Ware JH. The limitations of risk factors as prognostic tools. The New England Journal of Medicine 2006; 355(25):2615-2617.
7. O'Malley PG, Feuerstein IM, Taylor AJ. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. Journal of American Medical Association 2003; 289(17):2215-2223.